Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Rick Ducat points to Pfizer (PFE) as an underperformer in the healthcare sector and greater S&P 500 (SPX). However, shares of the company show some signs of strength that Rick believes sets the stage for a rebound even after the stock was hit with a recent downgrade. He offers a bearish options trade for Pfizer.

Morning Movers

06 Jul 2026

SHARE